These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 6099992)

  • 1. Dopamine D2 receptors modulate neurotransmitter-regulated calcium ion gates.
    Memo M; Spano PF
    Ann Ist Super Sanita; 1984; 20(1):5-10. PubMed ID: 6099992
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopaminergic inhibition of prolactin release and calcium influx induced by neurotensin in anterior pituitary is independent of cyclic AMP system.
    Memo M; Castelletti L; Missale C; Valerio A; Carruba M; Spano PF
    J Neurochem; 1986 Dec; 47(6):1689-95. PubMed ID: 2430058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Functional relation of dopamine receptor stimulation and ionic fluxes in lactotroph cells].
    Valerio A; Castelletti L; Boroni F; Missale C; Memo M
    Ann Ist Super Sanita; 1988; 24(4):543-5. PubMed ID: 3218803
    [No Abstract]   [Full Text] [Related]  

  • 4. Dopamine inhibition of neurotensin-induced increase in Ca2+ influx into rat pituitary cells.
    Memo M; Carboni E; Trabucchi M; Carruba MO; Spano PF
    Brain Res; 1985 Nov; 347(2):253-7. PubMed ID: 2415214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of dopamine and neurotensin on calcium fluxes and prolactin release in normal rat pituitary cells.
    Login IS; Kuan SI; Judd AM; MacLeod RM
    Endocrinology; 1990 Oct; 127(4):1948-55. PubMed ID: 1698150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine agonist action of phencyclidine.
    Seeman P; Lasaga M
    Synapse; 2005 Dec; 58(4):275-7. PubMed ID: 16206157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of neurotensin receptors associated with calcium channels and prolactin release in rat pituitary.
    Memo M; Castelletti L; Valerio A; Missale C; Spano PF
    J Neurochem; 1986 Dec; 47(6):1682-8. PubMed ID: 2430057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central administration of orexin A suppresses basal and domperidone stimulated plasma prolactin.
    Russell SH; Kim MS; Small CJ; Abbott CR; Morgan DG; Taheri S; Murphy KG; Todd JF; Ghatei MA; Bloom SR
    J Neuroendocrinol; 2000 Dec; 12(12):1213-8. PubMed ID: 11106980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotensin effect on calcium transport and dopamine release in rat striatum.
    Battaini F; Govoni S; Trabucchi M
    Regul Pept Suppl; 1985; 4():188-90. PubMed ID: 2414815
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary.
    Enjalbert A; Bockaert J
    Mol Pharmacol; 1983 May; 23(3):576-84. PubMed ID: 6306429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gigantism due to pituitary mammosomatotroph hyperplasia.
    Moran A; Asa SL; Kovacs K; Horvath E; Singer W; Sagman U; Reubi JC; Wilson CB; Larson R; Pescovitz OH
    N Engl J Med; 1990 Aug; 323(5):322-7. PubMed ID: 2164153
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of estrogens on tuberoinfundibular and striatal dopaminergic systems in the rat.
    Labrie F; Ferland L; Veilleux R; Euvrard C; Boissier J
    Acta Psychiatr Belg; 1980; 80(5):658-73. PubMed ID: 7234454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular mechanisms for neurotensin receptor-mediated release of prolactin.
    Memo M; Castelletti L; Valerio A; Pizzi M; Missale C; Carruba MO; Spano PF
    Regul Pept Suppl; 1985; 4():200-2. PubMed ID: 2997852
    [No Abstract]   [Full Text] [Related]  

  • 14. Tetrabenazine has properties of a dopamine receptor antagonist.
    Login IS; Cronin MJ; MacLeod RM
    Ann Neurol; 1982 Sep; 12(3):257-62. PubMed ID: 7137960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: 1. Activation of postsynaptic D3 receptors mediates hypothermia, whereas blockade of D2 receptors elicits prolactin secretion and catalepsy.
    Millan MJ; Peglion JL; Vian J; Rivet JM; Brocco M; Gobert A; Newman-Tancredi A; Dacquet C; Bervoets K; Girardon S
    J Pharmacol Exp Ther; 1995 Nov; 275(2):885-98. PubMed ID: 7473180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of yohimbine on rat prolactin secretion.
    Meltzer HY; Simonovic M; Gudelsky GA
    J Pharmacol Exp Ther; 1983 Jan; 224(1):21-7. PubMed ID: 6294278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative potency of LY141865 at dopamine DA2 and histamine H2 receptors.
    Ruffolo RR; Shaar CJ
    Eur J Pharmacol; 1983 Sep; 92(3-4):295-6. PubMed ID: 6226531
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibitors of prolactin secretion: a mini-review.
    Slaunwhite WR
    Prog Clin Biol Res; 1981; 75B():19-29. PubMed ID: 6275411
    [No Abstract]   [Full Text] [Related]  

  • 19. Reproductive experience and expression of dopamine D(2) receptor mRNA: a possible mechanism for reduced prolactin secretion in primiparous rats.
    Byrnes EM; Bridges RS
    J Neuroendocrinol; 2007 Oct; 19(10):773-8. PubMed ID: 17850459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Coupling of metabotropic receptors to ionic channels. Role of G-proteins].
    Lledo PM; Vernier P; Vincent JD
    C R Seances Soc Biol Fil; 1993; 187(1):7-13. PubMed ID: 7694780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.